Skip to main content
Show full summary

Lord Roberts of Llandudno to ask Her Majesty's Government what assessment they have made of reports that a COVID-19 placenta-based cell therapy, developed in Israel, has had a 100 per cent survival rate during clinical trials.  HL3216

Question HL3216: tabled on 21 April 2020 and due for answer by 5 May 2020

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Roberts of Llandudno to ask Her Majesty's Government what assessment they have made of reports that a COVID-19 placenta-based cell therapy, developed in Israel, has had a 100 per cent survival rate during clinical trials.  HL3216
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.